YOLAMIN

WIPO WIPO 2008

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke YOLAMIN wurde als Wortmarke am 23.12.2008 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 16. Juli 2019

Markenform Wortmarke
Aktenzeichen 991763
Länder Australien Schweiz China Japan Norwegen Vereinigte Staaten von Amerika (USA)
Basismarke EU Nr. 007037013, 04. Juli 2008
Anmeldedatum 23. Dezember 2008
Ablaufdatum 23. Dezember 2018

Markeninhaber

Lochhamer Str. 11
82152 Planegg, Martinsried
DE

Markenvertreter

Josephspitalstr. 15 80331 Munich DE

Waren und Dienstleistungen

05 Pharmaceutical and veterinary preparations for the prevention, treatment and/or diagnosis of diseases, in particular medicines, vaccines, serums and/or test kits for the prevention, treatment and/or diagnosis of tumour precursors, benign and malignant tumours, in particular warts, genital warts, neuronal tumours, glioma, astrocytoma, colon carcinoma, ovarian carcinoma, cervical cancer, prostate carcinoma, basal cell carcinoma, squamous cell carcinoma, melanoma, Kaposi's sarcoma, breast cancer, head and neck carcinomas, hepatocellular carcinoma, bronchial carcinoma, pancreatic tumours and/or renal tumours, autoimmune disorders, in particular rheumatoid arthritis, polyarthritis, Crohn's disease, lupus erythematosus and/or multiple sclerosis, neurodegenerative disorders, in particular Alzheimer's disease, Huntington's disease, multiple sclerosis, Parkinson's disease, schizophrenia, transmissible spongiform encephalopathy, bovine spongiform encephalopathy and/or Creutzfeldt-Jakob disease, rheumatic disorders, in particular rheumatoid arthritis, polychondritis, Bechterew's disease, fibromyalgia and/or lupus erythematosus, allergic diseases, in particular allergies, allergic rhinitis, hay fever, asthma, atopic eczema and/or insect sting allergies, cardiovascular disorders, in particular hyperlipidaemia, coronary artery disorders, cardiac insufficiency, high blood pressure and/or obesity, skin diseases, in particular warts, genital warts, Bowen's disease, actinic keratosis, seborrhoeic keratosis, psoriasis, dermatitis, eczema, acne, rosacea and/or herpes, infectious diseases, in particular viral infections, bacterial infections, parasitic infections and/or fungal infections and/or ophthalmic disorders, in particular age-dependent macular degeneration, glaucoma and/or retinoblastoma, in particular low-molecular active substances, liposomes, aptamers, nucleic acids, peptides, proteins, protein, conjugates, antibodies, T-cell proteins, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-type particles and/or plant extracts, in particular for oral, topical, intravenous and/or subcutaneous administration
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
06. Juli 2019 2019/27 Gaz Löschung
01. Juni 2017 2017/24 Gaz US RAW: Total Invalidation
14. Juni 2010 2013/3 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
11. März 2010 2010/11 Gaz JP RAW: Rule 18ter(2)(i) GP following a provisional refusal
25. Februar 2010 2010/14 Gaz EM RAW: Partial Ceasing Effect
15. Oktober 2009 2009/43 Gaz JP Ablehnung
03. August 2009 2009/32 Gaz NO RAW: Protection Granted
07. Juli 2009 2009/29 Gaz AU RAW: Protection Granted
25. März 2009 2009/14 Gaz US Ablehnung
23. Dezember 2008 2009/6 Gaz EM Eintragung

ID: 14991763